ArticleAntimicrobial agents and chemotherapy2026
A phase I study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of suraxavir marboxil: a novel oral antiviral for influenza.
Jing Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.